Cytochrome P450 Derived Eicosanoids and Inflammation

细胞色素 P450 衍生的类二十烷酸与炎症

基本信息

  • 批准号:
    8071142
  • 负责人:
  • 金额:
    $ 30.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Inflammation is a fundamental process which plays an integral role in the pathogenesis of numerous disease states in humans. Nuclear factor kappa B (NF-?B) is a central mediator of the inflammatory response via transcriptional activation of cytokine, chemokine and cellular adhesion molecule expression. Consequently, identification of novel strategies aimed at inhibition of this pathological process offers substantial therapeutic potential. Arachidonic acid is oxidatively metabolized by cytochrome P450 (CYP) epoxygenases from the CYP2J and CYP2C subfamilies to epoxyeicosatrienoic acids (EETs) in hepatic and extra-hepatic tissue. The EETs are rapidly hydrolyzed by soluble epoxide hydrolase (sEH) to less active dihydroxyeicosatrienoic acids (DHETs). Arachidonic acid is also metabolized to 20-hydroxyeicosatetraenoic acid (20-HETE) by CYP ?-hydroxylases from the CYP4A and CYP4F subfamilies. Recent evidence has demonstrated that CYP-derived EETs and 20-HETE possess anti- and pro-inflammatory effects, respectively. However, the contribution of CYP-mediated eicosanoid metabolism to the regulation of inflammation in vivo has not been rigorously characterized. We hypothesize that the functional balance between CYP epoxygenase- and CYP ?-hydroxylase-mediated arachidonic acid metabolism is integral to the regulation of NF-?B-mediated inflammatory responses in vivo, and modulation of this balance in favor of the CYP epoxygenase pathway offers substantial therapeutic potential. The primary objectives of this proposal are to: (1) define the impact of the inflammatory response on hepatic and extra-hepatic CYP-mediated eicosanoid metabolism, (2) define the functional role of CYP epoxygenase-mediated EET biosynthesis and sEH-mediated EET hydrolysis in the regulation of inflammation, and (3) characterize the relative impact of CYP epoxygenase and CYP ?-hydroxylase pathway modulation on inflammatory responses in vivo. This project will utilize novel transgenic and knock-out mice and pharmacological tools to manipulate CYP-mediated eicosanoid metabolism in vivo, while characterizing NF-?B-mediated inflammatory responses using established molecular biology and analytical techniques. Collectively, this series of novel experiments will define the mechanistic contribution of CYP epoxygenase-derived EETs and CYP ?-hydroxylase-derived 20-HETE to the regulation of hepatic and extra-hepatic inflammatory responses in vivo, and facilitate the development of new anti-inflammatory strategies with potential therapeutic application to numerous disease states in humans. PUBLIC HEALTH RELEVANCE: Inflammation is a fundamental process which plays an integral role in the pathogenesis of numerous diseases in humans. Completion of this research project will define the contribution of cytochrome P450-mediated eicosanoid metabolism to the regulation of inflammation in vivo, characterize the underlying mechanisms, and facilitate the development of novel therapeutic strategies aimed at inhibition of inflammation.
描述(由申请人提供):炎症是一个基本的过程,在人类许多疾病的发病机制中发挥着不可或缺的作用。核因子-kappaB是炎症反应的中枢介质,通过转录激活细胞因子、趋化因子和细胞黏附分子的表达。因此,识别旨在抑制这一病理过程的新策略提供了巨大的治疗潜力。花生四烯酸在肝脏和肝外组织中被细胞色素P450(CYP)环氧合酶氧化代谢成环氧二十碳三烯酸(EETs)。EETs被可溶性环氧化物水解酶(SEH)迅速水解为活性较低的二羟基二十碳三烯酸(DHETs)。花生四烯酸也被细胞色素P4A和细胞色素P4F亚家族的CYP?-羟基酶代谢成20-羟基二十碳四烯酸(20-HETE)。最近的证据表明,CYP来源的EETs和20-HETE分别具有抗炎和促炎作用。然而,CYP介导的二十烷类化合物代谢对体内炎症调节的贡献还没有得到严格的表征。我们推测,CYP环氧合酶和CYP羟基酶介导的花生四烯酸代谢之间的功能平衡是调节体内核因子B介导的炎症反应所不可或缺的,这种平衡的调节有利于CYP环氧合酶途径提供了巨大的治疗潜力。本研究的主要目的是:(1)明确炎症反应对肝脏和肝外CYP介导的二十烷类化合物代谢的影响;(2)明确CYP环氧合酶介导的EET生物合成和sEH介导的EET水解酶在调节炎症反应中的功能作用;(3)研究CYP环氧合酶和CYP-羟基酶途径调控对体内炎症反应的相对影响。该项目将利用新型转基因和基因敲除小鼠和药理学工具在体内操纵CYP介导的二十烷类化合物代谢,同时利用成熟的分子生物学和分析技术表征NF-B介导的炎症反应。总之,这一系列新颖的实验将确定CYP环氧合酶衍生的EETs和CYP?-羟基酶衍生的20-HETE在体内调节肝脏和肝外炎症反应中的机制贡献,并促进新的抗炎策略的开发,这些策略具有潜在的治疗人类多种疾病的应用。与公共卫生相关:炎症是一个基本的过程,在人类许多疾病的发病机制中发挥着不可或缺的作用。这项研究项目的完成将确定细胞色素P450介导的二十烷类代谢对体内炎症调节的贡献,表征潜在的机制,并促进旨在抑制炎症的新治疗策略的开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG R LEE其他文献

CRAIG R LEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG R LEE', 18)}}的其他基金

Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy
妊娠期肝脏药物代谢和转运改变的机制
  • 批准号:
    10613513
  • 财政年份:
    2020
  • 资助金额:
    $ 30.29万
  • 项目类别:
Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy
妊娠期肝脏药物代谢和转运改变的机制
  • 批准号:
    9903951
  • 财政年份:
    2020
  • 资助金额:
    $ 30.29万
  • 项目类别:
Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy
妊娠期肝脏药物代谢和转运改变的机制
  • 批准号:
    10380640
  • 财政年份:
    2020
  • 资助金额:
    $ 30.29万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    7903262
  • 财政年份:
    2009
  • 资助金额:
    $ 30.29万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8271446
  • 财政年份:
    2009
  • 资助金额:
    $ 30.29万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8304582
  • 财政年份:
    2009
  • 资助金额:
    $ 30.29万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8469053
  • 财政年份:
    2009
  • 资助金额:
    $ 30.29万
  • 项目类别:
GENOMIC PREDICTORS OF ENDOTHELIAL FUNCTION IN PATIENTS WITH ATHEROSCLEROTIC CARD
动脉粥样硬化患者内皮功能的基因组预测因子
  • 批准号:
    7716919
  • 财政年份:
    2008
  • 资助金额:
    $ 30.29万
  • 项目类别:
CYP2J2 Derived Eicosanoids and Endothelial Function
CYP2J2 衍生的类二十烷酸和内皮功能
  • 批准号:
    6742242
  • 财政年份:
    2003
  • 资助金额:
    $ 30.29万
  • 项目类别:
CYP2J2 Derived Eicosanoids and Endothelial Function
CYP2J2 衍生的类二十烷酸和内皮功能
  • 批准号:
    6806488
  • 财政年份:
    2003
  • 资助金额:
    $ 30.29万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 30.29万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了